Oligodendroglioma - 253 Studies Found
Not yet recruiting |
: Phase 1 Two Part Dose Escalation Trial of RRx-001 + Radiation + Temozolomide and RRx-001 + Temozolomide Post-RT In Newly Diagnosed Glioblastoma and Anaplastic Gliomas :
|
Recruiting |
: Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors :
: |
Completed |
: Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide :
|
Terminated |
: Treatment Strategy for Low-grade Gliomas :
|
Completed |
: Neural Basis of Language Processing :
|
Completed |
: Prolonged Daily Temozolomide for Low-Grade Glioma :
|
No longer available |
: Expanded Access to ANG1005 for Individual Patients :
: Drug: ANG1005 |
Completed |
: Topotecan in Treating Patients With Recurrent Brain Tumors : Brain and Central Nervous System Tumors : 1999-11-01 : Drug: topotecan hydrochloride |
Recruiting |
: First in Patient Study for PF-06840003 in Malignant Gliomas :
: Drug: PF-06840003 Daily Oral PF-06840003 |
Recruiting |
: A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas :
: Drug: Temozolomide 75 mg/m2/day for 21 days repeated every 4 weeks, 6 cycles. |